MEGIN announces sale of TRIUX™ neo to University of Nebraska Medical Center
HELSINKI, March 14, 2022 /PRNewswire/ -- MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technol...
Stay updated with breaking news from Neurological Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HELSINKI, March 14, 2022 /PRNewswire/ -- MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technol...
/PRNewswire/ -- MEGIN is delighted to announce the purchase of our fourth-generation magnetoencephalography (MEG) technology, the TRIUX™ neo, by the University...
Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple SclerosisMonday, March 14th @ 11 am ET, registration details below - read this article along with other careers information, tips and advice on BioSpace
Tiziana Life Sciences Ltd (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announced today that it will host a virtual Key Opinion Leader (KOL) webinar event, “Foralumab Clinical Update in Multiple Sclerosis: A Landmark ...
Monday, March 14th @ 11 am ET, registration details belowNEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling